https://www.selleckchem.com/pr....oducts/ldc195943-imt
Conclusion Implications for public health practices on university campuses are discussed.Supplemental data for this article can be accessed online at. Shengmai injection (SMI) has been used to treat heart failure. This study determines the molecular mechanisms of SMI against cardiotoxicity caused by doxorubicin (DOX). , DOX (15 mg/kg) was intraperitoneally injected in model, Dex (dexrazoxane), SMI-L (2.7 mL/kg), SMI-M (5.4 mL/kg), and SMI-H (10.8 mL/kg) for 7 consecutive days. Hematoxylin-eosin (HE) and Masson staining were used
Like
Comment
Share
